Screening and Intervention Reducing Anxiety in Patients With Implanted Cardioverter Defibrillator (ICD) - Screen-ICD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ICD
- Sponsor
- Rigshospitalet, Denmark
- Enrollment
- 88
- Locations
- 2
- Primary Endpoint
- Primary outcome is anxiety measured by HADS.
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The hypothesis is that there is a significant difference in anxiety scores between intervention and usual care group after intervention.
The aim of this randomised trial is (I) to determine the type of anxiety in ICD patients and (ii) to investigate the effect of screening followed by randomisation to intervention with consultations based on cognitive therapeutic principals to reduce anxiety in patients with ICD or usual care.
Detailed Description
Screen-ICD is an investigator-initiated randomised clinical superiority trial with blinded outcome assessment, including two university hospitals, with 1:1 randomisation to cognitive therapy plus usual care or usual care alone. The intervention: all patients receive usual care. Patients in the intervention group will receive an intervention based on cognitive behavioral therapy. The intervention consists of three steps: 1. The intervention begins with a consultation with a nurse aiming at uncovering anxiety using the Hamilton anxiety scale and exploring how life with an ICD is perceived, 2. Based on the pre-specified protocols for each type of anxiety, cognitive therapy is provided and 3. After each session participants are asked to fill out the HADS questionnaire. When the patient scores below the cut-off value two times in a row, sessions will end. Each patient can have a maximum of 15 sessions.
Investigators
Selina Kikkenborg Berg
Senior reseacher
Rigshospitalet, Denmark
Eligibility Criteria
Inclusion Criteria
- •Over 18 years
- •Have had ICD implantation
- •Speaks and understands Danish
- •Scores 8 or more in the HADS-A questionnaire
- •Gives written informed consent
Exclusion Criteria
- •Scores 11 or more in the HADS-D questionnaire and the depression score exceeds the anxiety score.
Outcomes
Primary Outcomes
Primary outcome is anxiety measured by HADS.
Time Frame: 16 weeks
HADS is a 14 item questionnaire that assesses anxiety and depression level in medical ill persons who are not admitted in psychiatric wards. Scores of 0 to 7 for either subscale are regarded as normal and scores of 8 to 10 suggest the presence of a mood disorder. Scores of 11 and above suggest probable presence of a mood disorder.
Secondary Outcomes
- Becks Anxiety Inventory (BAI)(16 weeks and 12 months)
- HeartQoL(16 weeks and 12 months)
- Anxiety measured by HADS.(12 months)
- Hamilton Anxiety Scale (HAM-A)(16 weeks and 12 months)